Cynata Therapeutics Limited

CYYNF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$6-$4-$5-$5
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$0$0$0
Other Non-Cash-$0$0-$1-$0
Operating Cash Flow-$6-$3-$5-$5
Investing Activities
PP&E Inv.$0-$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow$0-$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$7$0$0
Financing Cash Flow$0$7$0$0
Forex Effect$0-$0$0-$0
Net Chg. in Cash-$11$11-$11-$3
Supplemental Information
Beg. Cash$11$0$11$0
End Cash$0$11$0-$3
Free Cash Flow-$6-$3-$5-$5
Cynata Therapeutics Limited (CYYNF) Financial Statements & Key Stats | AlphaPilot